“Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated With JAK Inhibitor Tofacitinib Versus TNF Inhibitors: A Systematic Review, Meta Analysis, and Meta Regression”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia (December 10, 2025): 4. Accessed July 25, 2026. https://jimki.bapin.or.id/main/article/view/949.